000 02864cam a2200313 a 4500
003 EG-GiCUC
008 201027s2020 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.08.08.M.Sc.2020.Al.F
100 0 _aAlaa Ibrahim Mohamed Ali
245 1 0 _aFormulation and evaluation of biodegradable carriers for an antispasmodic drug /
_cAlaa Ibrahim Mohamed Ali ; Supervised Mohamed Aly Kassem , Khaled Fathy Elshaboury
246 1 5 _aصياغة و تقييم حوامل ذاتية التحلل لعقار مضاد للتقلصات
260 _aCairo :
_bAlaa Ibrahim Mohamed Ali ,
_c2020
300 _a147 P. :
_bcharts , facsmilies ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
520 _aOral dosage form is the most common and widely used route of administration, that{u2019}s mainly because; it is a simple, economical (solid oral dosage forms do not require sterile conditions),easy route of ingestion, flexible (suits several types of drug candidates), noninvasive (administration with pain avoidance), and most important it achieves both patient{u2019}s compliance and convenience. The large surface area of the gastrointestinal tract (300-400m2) is formed mainly of absorptive villi that is covered by enterocytes, goblet cells, and interspersed by follicle associated epithelium. The high transcytotic capacity of M cells covering these lymphoid regions (Peyer{u2019}s patches) increased their significance for drug delivery. Researchers are under constant pressure to find new methods for incorporating different technologies in oral dosage forms, even small enhancements in the technology of drug delivery can produce substantial enhancement in drug bioavailability and increase patient compliance. Now the majority of research projects are made to convert solid oral formulations into controlled dosage forms. The newly produced controlled release dosage forms are capable of achieving both sustained and controlled release. Polymers are the main component in producing controlled release dosage forms, due to their unique characteristics such as swellability, bioerosion and biodegradation in body fluids. The main purpose of controlled release dosage forms is to maintain the drug concentration in the body.Treatments of chronic diseases are the most potential drug candidates to be formulated as controlled release dosage forms
530 _aIssued also as CD
653 4 _aANOVA (analysis of variance)
653 4 _aAntispasmodic drug
653 4 _aBiodegradable carriers
700 0 _aKhaled Fathy Elshaboury ,
_eSupervisor
700 0 _aMohamed Aly Kassem ,
_eSupervisor
905 _aAmira
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c78468
_d78468